Format

Send to

Choose Destination
Eur J Hum Genet. 2015 Jul;23(7):893-900. doi: 10.1038/ejhg.2014.235. Epub 2014 Nov 19.

BBMRI-ERIC as a resource for pharmaceutical and life science industries: the development of biobank-based Expert Centres.

Author information

1
Department of Human Genetics, Leiden University Medical Center, Leiden, The Netherlands.
2
Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.
3
Institut Pasteur, Paris, France.
4
BIOBANQUES Infrastructure, Inserm US 13, Hopital de la Salpetriere, Paris, France.
5
Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
6
Department of Public Health and General Practice, Norwegian University of Science and Technology, Trondheim, Norway.
7
Magnetic Resonance Center, University of Florence, Florence, Italy.
8
The Estonian Genome Center, University of Tartu, Tartu, Estonia.
9
Uppsala University Innovation, Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
10
Lifandis AS, Levanger, Norway.
11
1] Institute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland [2] Department of Chronic Disease Prevention, National Institute for Health and Welfare, Helsinki, Finland.
12
Biobanking and Biomolecular Resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC), Graz, Austria.
13
Institute of Pathology, Medical University of Graz, Graz, Austria.

Abstract

Biological resources (cells, tissues, bodily fluids or biomolecules) are considered essential raw material for the advancement of health-related biotechnology, for research and development in life sciences, and for ultimately improving human health. Stored in local biobanks, access to the human biological samples and related medical data for transnational research is often limited, in particular for the international life science industry. The recently established pan-European Biobanking and BioMolecular resources Research Infrastructure-European Research Infrastructure Consortium (BBMRI-ERIC) aims to improve accessibility and interoperability between academic and industrial parties to benefit personalized medicine, disease prevention to promote development of new diagnostics, devices and medicines. BBMRI-ERIC is developing the concept of Expert Centre as public-private partnerships in the precompetitive, not-for-profit field to provide a new structure to perform research projects that would face difficulties under currently established models of academic-industry collaboration. By definition, Expert Centres are key intermediaries between public and private sectors performing the analysis of biological samples under internationally standardized conditions. This paper presents the rationale behind the Expert Centres and illustrates the novel concept with model examples.

PMID:
25407005
PMCID:
PMC4463510
DOI:
10.1038/ejhg.2014.235
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Nature Publishing Group Icon for PubMed Central
Loading ...
Support Center